BIIB vs RVMD: stock comparison and AI forecast
Biogen Inc. (BIIB) and Revolution Medicines, Inc. (RVMD) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
BIIB Biogen Inc.
- Market Cap
- $36.06B
- P/E Ratio
- 105.1x
- Size
- large-cap
- AI Forecast
RVMD Revolution Medicines, Inc.
- Market Cap
- $42.80B
- P/E Ratio
- –
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- RVMD is 1.2 times larger than BIIB by market capitalization ($42.80B against $36.06B).
- BIIB turns 3.4% of its revenue into net income, against -946.8% for RVMD.
- RVMD carries 0.79 times debt per unit of equity, against 0.69 times for BIIB.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | BIIB | RVMD |
|---|---|---|
| Market Cap | $36.06B | $42.80B |
| P/E Ratio | 105.14x | – |
| P/B Ratio | 1.91x | 17.82x |
| EPS | $2.32 | $-9.15 |
| Book Value/Share | $128.01 | $11.20 |
| Revenue/Share | $69.66 | – |
| FCF/Share | $14.01 | $-6.72 |
Profitability & Margins
| Metric | BIIB | RVMD |
|---|---|---|
| ROE | 1.8% | -77.9% |
| ROA | 1.1% | -43.5% |
| ROIC | – | -44.0% |
| Gross Margin | 74.0% | – |
| Operating Margin | – | -853.0% |
| Net Margin | 3.4% | -946.8% |
| EBT Margin | 4.3% | -948.0% |
| Tax Rate | 21.9% | 0.2% |
Financial Health
| Metric | BIIB | RVMD |
|---|---|---|
| Current Ratio | 1.95x | 8.36x |
| Quick Ratio | 1.37x | 8.34x |
| D/E Ratio | 0.69x | 0.79x |
| Financial Leverage | 1.69x | 1.79x |
| Interest Coverage | 9.2x | -3116.4x |
| Working Capital | $3.69B | $3.50B |
Cash Flow
| Metric | BIIB | RVMD |
|---|---|---|
| Operating Cash Flow | $2.25B | -$1.43B |
| Free Cash Flow | $2.07B | -$1.44B |
| Capital Spending | -$176M | -$9M |
| OCF Growth YoY | -8.4% | – |
| FCF Growth YoY | -10.1% | – |
| FCF/Sales | 20.1% | – |
| CapEx/Sales | 1.7% | – |
Operational Efficiency
| Metric | BIIB | RVMD |
|---|---|---|
| Asset Turnover | 0.32x | – |
| Inventory Turnover | 1.2x | – |
| Fixed Assets Turnover | 3.5x | – |
| Days Inventory | 303 days | – |
| Payables Period | 59 days | – |
Income Statement
| Metric | BIIB | RVMD |
|---|---|---|
| Total Revenue | $10.30B | – |
| Operating Income | – | -$1.69B |
| Net Income | $348M | -$1.87B |
| R&D Expense | $2.15B | $1.45B |
| SG&A Expense | $2.75B | – |
| Cost of Goods Sold | $2.68B | – |
Dividend & Shareholder Information
| Metric | BIIB | RVMD |
|---|---|---|
| Shares Outstanding | 148M | 214M |
| Net Income Growth | -78.4% | – |
| EPS Growth | -78.8% | – |
BIIB vs RVMD: stock comparison and AI forecast
Which is bigger, BIIB or RVMD?
RVMD is 1.2 times larger than BIIB by market capitalization ($42.80B against $36.06B).
Which one does Intratio's AI model rank higher, BIIB or RVMD?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.